弗雷尔被评为埃弗雷斯特集团2024年生命科学监管和医疗事务运营PEAK Matrix®评估的领导者. Freyr named Leader in Everest Group's 2024 Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix® Assessment.

Freyr是生命科学监管解决方案的全球提供者,被确认为珠穆朗玛峰集团2024年生命科学监管和医疗事务行动“EAK 矩阵”评估的牵头人。 Freyr, a global provider of regulatory solutions for life sciences, has been recognized as a Leader in Everest Group's 2024 Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix® Assessment. 这一认识突出了弗雷尔的广泛市场存在、强有力的附属网络、本地专门知识和AI-Freya Fusion第一平台,使其能够在不同监管环境中满足客户的数字化和效率需求。 This recognition highlights Freyr's extensive market presence, robust affiliate network, localized expertise, and AI-first Freya Fusion platform, enabling it to address clients' digitization and efficiency needs in diverse regulatory environments.